Shandong Pharmaceutical Glass Co Ltd (600529) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Pharmaceutical Glass Co Ltd (600529) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥41.46 Million ≈ $6.07 Million USD) by net assets (CN¥8.29 Billion ≈ $1.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shandong Pharmaceutical Glass Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Shandong Pharmaceutical Glass Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600529 current and long-term liabilities for a breakdown of total debt and financial obligations.
Shandong Pharmaceutical Glass Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Pharmaceutical Glass Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Walker & Dunlop Inc
NYSE:WD
|
-0.533x |
|
Siloam International Hospitals
JK:SILO
|
0.042x |
|
Berli Jucker PCL
BK:BJC
|
0.035x |
|
Relay Therapeutics Inc
NASDAQ:RLAY
|
-0.079x |
|
SPG Co. Ltd
KQ:058610
|
0.063x |
|
Gujarat State Petronet Limited
NSE:GSPL
|
0.104x |
|
Guangzhou Goaland Energy Conservation Tech Co Ltd
SHE:300499
|
0.027x |
|
Dongguan Eontec Co Ltd
SHE:300328
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Shandong Pharmaceutical Glass Co Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see 600529 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.29 Billion ≈ $1.21 Billion |
CN¥576.92 Million ≈ $84.42 Million |
0.070x | -52.19% |
| 2024-12-31 | CN¥8.01 Billion ≈ $1.17 Billion |
CN¥1.17 Billion ≈ $170.48 Million |
0.145x | +4.60% |
| 2023-12-31 | CN¥7.53 Billion ≈ $1.10 Billion |
CN¥1.05 Billion ≈ $153.35 Million |
0.139x | +283.58% |
| 2022-12-31 | CN¥6.96 Billion ≈ $1.02 Billion |
CN¥252.44 Million ≈ $36.94 Million |
0.036x | -77.43% |
| 2021-12-31 | CN¥4.67 Billion ≈ $683.41 Million |
CN¥750.44 Million ≈ $109.81 Million |
0.161x | +20.82% |
| 2020-12-31 | CN¥4.26 Billion ≈ $622.77 Million |
CN¥566.01 Million ≈ $82.82 Million |
0.133x | -14.13% |
| 2019-12-31 | CN¥3.87 Billion ≈ $565.98 Million |
CN¥599.05 Million ≈ $87.66 Million |
0.155x | +17.24% |
| 2018-12-31 | CN¥3.53 Billion ≈ $515.92 Million |
CN¥465.77 Million ≈ $68.16 Million |
0.132x | +4.23% |
| 2017-12-31 | CN¥3.25 Billion ≈ $475.62 Million |
CN¥411.96 Million ≈ $60.28 Million |
0.127x | -23.84% |
| 2016-12-31 | CN¥3.04 Billion ≈ $445.37 Million |
CN¥506.53 Million ≈ $74.12 Million |
0.166x | -4.43% |
| 2015-12-31 | CN¥2.24 Billion ≈ $327.41 Million |
CN¥389.63 Million ≈ $57.02 Million |
0.174x | +38.83% |
| 2014-12-31 | CN¥2.13 Billion ≈ $311.04 Million |
CN¥266.63 Million ≈ $39.02 Million |
0.125x | -5.20% |
| 2013-12-31 | CN¥2.03 Billion ≈ $297.05 Million |
CN¥268.60 Million ≈ $39.30 Million |
0.132x | +800.22% |
| 2012-12-31 | CN¥1.94 Billion ≈ $283.93 Million |
CN¥28.52 Million ≈ $4.17 Million |
0.015x | -90.10% |
| 2011-12-31 | CN¥1.85 Billion ≈ $270.68 Million |
CN¥274.63 Million ≈ $40.19 Million |
0.148x | +19.41% |
| 2010-12-31 | CN¥1.75 Billion ≈ $255.40 Million |
CN¥217.01 Million ≈ $31.76 Million |
0.124x | -20.53% |
| 2009-12-31 | CN¥1.59 Billion ≈ $233.14 Million |
CN¥249.27 Million ≈ $36.48 Million |
0.156x | +147.67% |
| 2008-12-31 | CN¥1.45 Billion ≈ $212.56 Million |
CN¥91.76 Million ≈ $13.43 Million |
0.063x | -32.69% |
| 2007-12-31 | CN¥1.31 Billion ≈ $191.22 Million |
CN¥122.63 Million ≈ $17.95 Million |
0.094x | +10.60% |
| 2006-12-31 | CN¥924.74 Million ≈ $135.32 Million |
CN¥78.47 Million ≈ $11.48 Million |
0.085x | +65.83% |
| 2005-12-31 | CN¥861.57 Million ≈ $126.08 Million |
CN¥44.09 Million ≈ $6.45 Million |
0.051x | +1202.83% |
| 2004-12-31 | CN¥797.19 Million ≈ $116.65 Million |
CN¥-3.70 Million ≈ $-541.26K |
-0.005x | -105.67% |
| 2003-12-31 | CN¥725.23 Million ≈ $106.12 Million |
CN¥59.35 Million ≈ $8.68 Million |
0.082x | -51.29% |
| 2002-12-31 | CN¥650.32 Million ≈ $95.16 Million |
CN¥109.26 Million ≈ $15.99 Million |
0.168x | +31.77% |
| 2001-12-31 | CN¥224.34 Million ≈ $32.83 Million |
CN¥28.60 Million ≈ $4.19 Million |
0.128x | -- |
About Shandong Pharmaceutical Glass Co Ltd
Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection v… Read more